Synagis and Tacrolimus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Synagis (palivizumab) and Tacrolimus (tacrolimus). Common drug interactions include infection among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Synagis and Tacrolimus. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Synagis?

Synagis has active ingredients of palivizumab. eHealthMe is studying from 19,114 Synagis users. Check the latest studies of Synagis.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,160 Tacrolimus users. Check the latest studies of Tacrolimus.

On Jul, 16, 2026

15 people who take Synagis and Tacrolimus together, and have interactions are studied.

Synagis and Tacrolimus drug interactions.

What are the common drug interactions of Synagis and Tacrolimus, by gender? *:

female:

Infection
Pneumonia
Feeding disorder (when children refuse to eat certain food groups)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Hepatic enzyme increased
Cardiac hypertrophy (thickening of the heart muscle)
Transplant rejection (a transplant material is not worked)

male:

Diarrhoea
Vomiting
Pyrexia (fever)
Respiratory syncytial virus infection (viral disease of respiratory system)
Cough
Eating disorder
Hyperhidrosis (abnormally increased sweating)
Rhinorrhoea (watery mucus discharge from the nose)
Weight decreased
Blood bicarbonate decreased

What are the common drug interactions of Synagis and Tacrolimus, by age (0-1 to 60+)? *:

0-1:

Penile ulceration
Cough
Eating disorder
Hyperhidrosis (abnormally increased sweating)
Pyrexia (fever)
Respiratory syncytial virus infection (viral disease of respiratory system)
Rhinorrhoea (watery mucus discharge from the nose)
Vomiting
Cardiac hypertrophy (thickening of the heart muscle)
Abdominal pain

2-9:

Infection
Pneumonia

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 6.67%
Neonatal Aspiration (aspiration by neonate): 1 person, 6.67%
Immunodeficiency: 1 person, 6.67%
Graft Versus Host Disease In Skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin): 1 person, 6.67%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 6.67%
Gastrointestinal Malformation: 1 person, 6.67%
Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 1 person, 6.67%
Bronchopulmonary Dysplasia (chronic lung disorder in infants - enlargement of an organ or tissue by the proliferation of cells of an abnormal type): 1 person, 6.67%
Acute Respiratory Failure: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Synagis and Tacrolimus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously